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Towards a standardized bioinformatics
infrastructure for N- and O-glycomics
Miguel A. Rojas-Macias1, Julien Mariethoz 2,3, Peter Andersson1,
Chunsheng Jin1, Vignesh Venkatakrishnan 1, Nobuyuki P. Aoki4,5,
Daisuke Shinmachi 4,5, Christopher Ashwood 6,7, Katarina Madunic 8,
Tao Zhang8, Rebecca L. Miller 9, Oliver Horlacher2, Weston B. Struwe10,
Yu Watanabe11, Shujiro Okuda 11, Fredrik Levander 12, Daniel Kolarich 13,14,
Pauline M. Rudd15, Manfred Wuhrer8, Carsten Kettner 16,
Nicolle H. Packer 6,13,14, Kiyoko F. Aoki-Kinoshita 4,
Frédérique Lisacek 2,3,17 & Niclas G. Karlsson 1
The mass spectrometry (MS)-based analysis of free polysaccharides and glycans released
from proteins, lipids and proteoglycans increasingly relies on databases and software. Here,
we review progress in the bioinformatics analysis of protein-released N- and O-linked glycans
(N- and O-glycomics) and propose an e-infrastructure to overcome current deﬁcits in
data and experimental transparency. This workﬂow enables the standardized submission of
MS-based glycomics information into the public repository UniCarb-DR. It implements the
MIRAGE (Minimum Requirement for A Glycomics Experiment) reporting guidelines, storage
of unprocessed MS data in the GlycoPOST repository and glycan structure registration using
the GlyTouCan registry, thereby supporting the development and extension of a glycan
structure knowledgebase.
Posttranslational modiﬁcations of proteins play an essential role in modifying amino acidsin proteins, thereby extending their functions and regulating their activities. A census of allpossible protein forms, now commonly called proteoforms, was recently estimated1. In this
renewed view of protein diversity, glycoforms are increasingly being shown to play a major role
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in both health and disease2–5. In fact, glycosylation has been
shown to be involved in the vast majority of cellular interactions
and complex networks. Glycosylation is the basis of most biolo-
gical events, including protein structural stability, recognition,
immunological responses, cancer metastasis and the attachment
of pathogens to host cells as the ﬁrst step in the process of
infection6,7. Furthermore, the importance of glycosylation is
highlighted by the extreme consequences of genetic defects in the
glycosylation machinery8. Congenital Disorders of Glycosylation
are a result of the loss of function of different enzymes involved in
N-linked and O-linked oligosaccharide biosynthesis9, resulting in
severe illness, organ failure and premature death. The importance
of protein glycosylation demands that technologies used for
structural determination and function are accurate, robust, and
information-rich.
Here, we review the latest mass spectrometry (MS) technology
for analysing released N- and O-linked glycans. We also describe
the progress that has been made in glycobioinformatics software
as well as structural/experimental databases and repositories. As
researchers are requested to submit an increasing amount of
analytical data into public repositories, we propose a standardized
workﬂow for MS glycomics data recording based on community
reporting guidelines and uploading of structural and experi-
mental data to tailor-made databases and repositories.
Methods and reporting standards for MS-based glycomics
Structural characterisation of glycans by MS. At a ﬁrst
glance, MS is not the ideal choice for structural characterisation of
glycans. While a precursor mass is sufﬁcient to assign a compo-
sition (e.g. the number of constituting hexoses, N-acetylhex-
osamines etc.), it will not allow distinguishing between different
isomeric structures, which is one of the major obstacles in the
characterisation of glycans. A single mass measurement cannot
resolve different isomeric monosaccharides such as glucose,
mannose or galactose, nor does MS allow the assignment of
pyranose, furanose or linear forms, or differentiation of enan-
tiomers (D or L form).
More detailed insights into glycan structures can be obtained
through MS/MS experiments, whereby the glycans are fragmen-
ted in the mass spectrometer. MS/MS CID (collision induced
dissociation) and HCD (higher-energy collisional dissociation)
fragmentation can help to determine, the primary sequence of a
glycan, including branching points and elongation. However,
additional input is required to identify the glycan linkage position
(e.g., 1, 2, 3, 4 and 6) and conﬁguration (α or β). Knowledge about
the principles and rules of glycan biosynthesis—gained from
structural gycobiology work using for instance NMR and studies
characterising glycosyltransferase speciﬁcity—can reduce the
number of conceivable MS assignments. In addition, speciﬁc
cross-ring fragmentation in CID and HCD can sometimes enable
linkage position assignment10,11. However, to fully assign a novel
structure, a combination of MS, biosynthetic rules, chemical and
enzymatic treatment, monosaccharide analysis, retention time
and/or NMR is necessary. Multistage MSn fragmentation12, ion
mobility MS13 and ion spectroscopy14,15 can also be used to
reduce the number of conceivable MS assignments. Furthermore,
electron activation fragmentation techniques (referred to as ExD
techniques)16 such as electron capture dissociation (ECD),
electron transfer dissociation (ETD), electronic excitation dis-
sociation (EED) and electron detachment dissociation (EDD)
have been shown to provide extensive cross ring fragmentation
allowing more detailed structural characterisation of glycans.
Despite its limitations, MS has become the central tool for the
study of protein glycosylation, largely due to its speed, high
sensitivity, partial structural identiﬁcation and capacity to deal
with mixtures, and has been used extensively for glycomic
screening/proﬁling17,18. The glycomic proﬁling of free and/or
released glycans by MS has involved the use of a considerable
variety of upfront dedicated isolation, derivatization and
characterisation techniques that, together with increasingly
sophisticated MS instrumentation, has been used to increase
speed, depth and efﬁciency of analysis. A generic glycomic
workﬂow for N- and O-glycans released from proteins has been
described before19 and is summarized in Fig. 1.
It is important to point out that this review is focused on
protein-based glycomics - which is different from glycoproteo-
mics. While glycomics can generate detailed information about
glycan structure(s), the methods used to release the glycans from
the protein inevitably obliterate the localisation of the glycosyla-
tion site within a protein/peptide sequence. Glycoproteomics on
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Fig. 1 General Overview of a glycomics MS workﬂow. The analytical options at each step are shown below. A similar workﬂow has been described in ref. 19.
TOF time of ﬂight mass analyzer, TOF/TOF TOF tandem MS, Q quadrupole mass analyzer, QTOF tandem MS combining Q and TOF, IT ion trap mass
analyzer, QIT dual operational Q and IT MS, QIT-TOF QIT combined with TOF tandem MS; LTQ(-IT), linear trap quadrupole mass analyser (a linear ion
trap), LTQ-TOF tandem MS combining LTQ and TOF, IM ion mobility, IM-QTOF ion mobility cell/QTOF mass spectrometer, FT-ICR Fourier-transform ion
cyclotron resonance mass analyzer, LTQ FT-ICR tandem MS combining LTQ and FT-ICR, LTQ-Orbitrap tandem MS combining LTQ and Orbitrap, LIT linear
ion trap, Qh quadrupole/hexapole interface, TIMS trapped ion mobility spectrometry
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the other hand tries to address glycosylation by analysing
intact glyco-peptides/proteins. The caveat is that traditional
fragmentation used on (glyco)peptides such as CID and HCD
only provide limited information about oligosaccharide structure,
and even site localisation can sometimes be difﬁcult due to loss of
the entire glycan20. In this context, ECD and later on ETD
showed to be the fragmentation methods of choice for site
localisation of glycans, since the fragmentation occurs primarily
in the peptide chain20,21. Glycoproteomics analysis, at this stage,
therefore can identify the site and mass (composition) of the
glycan(s) on a particular site, but provides little details about
glycan sequence, branching or linkage.
Comparative glycomics. The goal of a glycomic experiment is
not always to fully characterise all glycan structures in a sample.
Instead, glycomic proﬁling is often applied to compare samples
and focuses on the identiﬁcation of abnormalities and differences.
Several approaches such as MS, HPLC, LC-MS and capillary
electrophoresis are used for glycomic proﬁling. They provide
different levels of glycan characterisation ranging from mass
proﬁling, to partial sequence and full structural assignments
(based on complementary information), to absolute or relative
quantiﬁcation of individual structures in a biological sample.
In label-free MS-based analyses, the abundances of pseudo-
molecular ions (e.g. [M – nH]n− or [M+ nNa]n+ ions) are used
to identify differences between samples. Furthermore, several
quantitative glycomics methods are based on derivatization
approaches and heavy labelled isotopes (reviewed in refs. 22–24).
Quantiﬁcation using stable isotope standards and MS has been
shown to provide excellent precision in glycomics25–27 and
glycoproteomics28. However, the low number of freely available
stable isotope standards is currently the limiting factor for
implementing absolute quantitation in MS-based glycomics for a
wider range of glycans available from single cells or tissues.
Relative quantiﬁcation using ﬂuorescent tagging in connection
with HPLC or capillary electrophoresis provides the beneﬁt of
stoichiometric response from individual glyco components and is
the gold standard for glycomic relative quantiﬁcation29. Cross-
laboratory comparisons have shown that MS can provide similar
quantiﬁcation results30,31, where differences between laboratories
can mainly be attributed to differences in sample preparation
and data accumulation protocols. This illustrates the need to
accurately record protocols for structural assignment of a well-
deﬁned sample data and sample handling protocols, and
quantitative aspect.
Adopting omics reporting guidelines for glycomics. MS based
omics entails analysing a multitude of samples generating large
amounts of data, and using software to transform these data into
biological information. To make this process transparent and
reproducible, there is a need for consistent reporting of experi-
mental methods and procedures in publications. Many omics
ﬁelds have addressed these concerns by developing guidelines for
the reporting, collecting and distributing of data and information.
This started with MIAME launched for the handling of micro-
arrays32, followed by the MIAPE guidelines for proteomics33,
STRENDA in enzymology34,35, CIMR in metabolomics36,37
among others. There are currently more than 150 reporting
guidelines published and registered in the FAIRSharing portal38.
As was discussed in the previous paragraph, structural
characterisation of glycans using only MS is difﬁcult. Multiple
guidelines are required for the multiple techniques that are used
to convert the analytical data into detailed structural glycomic
information. To acknowledge the complexity of glycan structural
characterisation, the glycomics community launched the
MIRAGE (Minimum Information Required for A Glycomics
Experiment) initiative in 2011. The MIRAGE initiative is formed
by experts from the diverse areas of glycomics research and
supported by the Beilstein-Institut39. Up to now this has resulted
in guidelines for glycomics sample preparation40 (https://doi.org/
10.3762/mirage.1), MS analysis41 (https://doi.org/10.3762/
mirage.2), glycan microarray analysis42 (https://doi.org/10.3762/
mirage.3), and liquid chromatography analysis43 (https://doi.org/
10.3762/mirage.4). The MS guidelines require not only reporting
of experimental conditions, but also disclosure of raw MS data
and annotated spectra. Making these guidelines widely applicable
require the development of workﬂows that describe what is to be
reported and how to record glycomics MS data. In addition,
adoptability of the guidelines requires a web-based software
pipeline that facilitates the ﬂow from MS data acquisition to
public disclosure of raw data and reporting of data structural
interpretation/annotation.
The current landscape of glycomic e-infrastructures
Glycan structure repositories. In 2008, the NIH work group
“Frontiers in glycomics” emphasised the need for a curated, sus-
tainably funded glyco-structure database44. Accounting for the
variety of analytical methods used to assign glycan structures, the
proposed structural database was expected to contain associated
information about experimental and biosynthetic data. Pioneering
attempts to create a comprehensive glycomic database were made in
the 1980s with Carbank45. The Carbank institutors also imple-
mented regular updates with information from new publications.
Unfortunately, a funding crisis stopped this effort in the 1990s and
the project was discontinued, but the assembled data lived on in the
next-generation databases including SWEET-DB46 and Glycosui-
teDB47 (later incorporated into UniCarbKB48 and GlyConnect49,
both having the same agenda as their ancestor. Then, integrative
initiatives arose with the goal of centralising scattered data (e.g.
GlycomeDB50), as well as combining it with in silico analytical tools
such as GLYCOSCIENCES.de51, KEGG GLYCAN52,53 and repo-
sitories provided by the Consortium for Functional Glycomics
(CFG, http://www.functionalglycomics.org/fg/). The progress
in the ﬁeld was somewhat chaotic at the turn of the century,
but has signiﬁcantly evolved lately through a new generation of
centralised and integrative resources, each one located on a different
continent and being developed in mutual recognition. These are
GlyGen in the US (http://www.glygen.org/), Glycomics@ExPASy54
(https://www.expasy.org/glycomics) in Europe and GlyCosmos in
Japan (https://glycosmos.org/). This recent trend may ﬁnally pro-
vide a long-term solution for stable and ﬁnancially supported
resources for glycobiology. For instance, GlyCosmos includes Gly-
TouCan (https://glytoucan.org/)55, a registry that provides glycan
structures with unique identiﬁers. GlyTouCan provides a founda-
tion for developing complementary repositories, where each unique
glycan recorded can be associated with additional experimental
information, such as MS data, HPLC retention times and NMR
spectra.
Bioinformatic resources for MS-based glycomics. To capture
information contained in glycomics MS/MS data, UniCarb-DB
was launched in 201156,57. Since its introduction, several versions
of UniCarb-DB have been released, mainly to improve the gly-
comics data quality, to increase the number of entries and to
advance the usability of the application. UniCarb-DB is currently
integrated in Glycomics@ExPASy and provides the framework
for accessing experimental MS data that comprise fragmentation
spectra, associated structures and metadata about biological ori-
gin. Currently, UniCarb-DB contains structural and fragmenta-
tion data of O-glycans and N-glycans obtained in positive and
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negative MS ion modes. Additional MS fragmentation spectra of
glycans are provided in the NIST Glycan Mass Spectral Reference
Library (https://chemdata.nist.gov/glycan/spectra)58.
In parallel to the expansion of glycan structure databases, there
has been slow but steady progress in the development of software
for glycomics data analysis. The early GlycosidIQ automated the
comparison of observed fragments with theoretical glyco-
fragments derived from a structural database59. This approach
has been adopted in commercial software60. GlycoReSoft was
developed to aid glycan detection from LC-MS runs to compare
different samples61. Other approaches convert mass spectra into
structures relying on spectral libraries57,62. More advanced tools
for glycomics analysis use partial de novo sequencing63 including
GlycoDeNovo64 and the recently published Glycoforest65. High-
throughput glycomics MS annotation tools (GRITS Toolbox66,
www.grits-toolbox.org/) and quantitation tools67 are now avail-
able and increase the need for a common data exchange format.
Providing data in an agreed format will help to make data
publicly accessible, so that they can be scrutinized by others and
used for the validation and curation of glycan structures, for
instance those deposited in the GlyTouCan registry.
A mirage-compatible e-infrastructure for MS-based
glycomics
In order to implement the MIRAGE guidelines39 into an MS-
based glycomics e-infrastructure, two existing guidelines were
used; (1) glycomic sample preparation40 and (2) deﬁned MS
conditions41. The curators also proposed a HPLC experimental
module, expanding on the guidelines to enable recording of LC-
MS parameters. This section is planned to be expanded since the
MIRAGE LC-guidelines recently were published43.
This ﬁrst version of a data recording workﬂow will focus efforts
on the most essential implementation of qualitative, structural
information. Quantiﬁcation guidelines will only be addressed at a
superﬁcial level, with expected expansion in subsequent versions.
This can be justiﬁed considering that workﬂows for quantitative
glycomics are still evolving and that the basic level of methods
and software tools is yet to become common practice. Due to the
lack of a long-term global public repository for MS glycomics raw
data, the requirement to provide this quantitative information as
part of the submission has not yet set to be compulsory.
To support an e-workﬂow, we created the data repository
UniCarb-DR (http://unicarb-dr.biomedicine.gu.se/) to facilitates
submission of glycomics MSn data in compliance with the
MIRAGE guidelines as part of a publication submission process
(Fig. 2). This repository will serve as the interim storage of
experimental MS fragment data and structures before data
curation and annotation and subsequent transition into the
UniCarb-DB database. An author can browse and re-enter sub-
mitted data before it is uploaded to the UniCarb-DB repository.
We assume that in the near future journals will require data
submission to be compulsory prior to publication as for other
omics data. Hence, the user can submit the data, referring to it as
a “manuscript”. For data uploaded after publication, PubMed ID
(PMID), available from https://www.ncbi.nlm.nih.gov/pubmed/
can be included.
Data deposition in the repository ﬁrst requires user registration
and login at http://unicarb-dr.biomedicine.gu.se/signup. Next, the
user must provide a number of ﬁles and information (Fig. 2)
including:
(1) A compiled ﬁle with MIRAGE data (see example spread-
sheet in Supplementary Data 1).
(2) Compiled information about structures (proposed format is
GlycoWorkbench)68.
(3) Location of publicly accessible unprocessed MS ﬁles.
(4) Unique structure identiﬁer (this information is automati-
cally generated by communication between UniCarb-DR
and the GlyTouCan structural repository55).
Further information about these four steps is provided below.
A detailed protocol for how to ﬁll in spreadsheets, Glyco-
Workbench ﬁles and how submit data to UniCarb-DR is available
in Supplementary Note 1.
Step 1: Recording MIRAGE data using webform. Experimental
data needs to be provided in a spreadsheet with data ﬁelds
reﬂecting the general structure of the MIRAGE guidelines. Pre-
ﬁlling and downloading of the MIRAGE compliant spreadsheets
are possible in the web form (http://unicarb-dr.biomedicine.gu.se/
generate). Three different spreadsheets are available: (1) sample
preparation, (2) LC and (3) MS guidelines. These can be gener-
ated individually or combined into one ﬁle containing several
sheets (see Supplementary Data 1). These spreadsheets can be
Structure unique
identifier
Structure
User
Curation of data
- Scoring
- MS/MS annotated peaks
- Quality control/selection
Glycomics MS metadata (.xls)
Annotated glycomics data (.gwp)MS raw file
Re
tur
nin
g ID
s
Fig. 2 Workﬂow for MIRAGE data submission to UniCarb-DR. The workﬂow was designed to support the MIRAGE guidelines for sample preparation,
including HPLC, MS and annotation. Metadata that are relevant to the entire experiment can be manually recorded in the on-line form accessible on the
UniCarb-DR website (http://unicarb-dr.biomedicine.gu.se/) that automatically generates spreadsheets (.xls). GlycoWorkBench ﬁles (.gwp) are proposed
to be used for data annotation of individual structures. MS raw ﬁles can be submitted to GlycoPOST and returned IDs can be included in the MIRAGE
report. UniCarb-DR also communicates with the global glycostructure repository GlyTouCan to generate unique identiﬁers for structures submitted to
UniCarb-DR. UniCarb-DR will become one source of curated data in UniCarb-DB
REVIEW ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-11131-x
4 NATURE COMMUNICATIONS |         (2019) 10:3275 | https://doi.org/10.1038/s41467-019-11131-x | www.nature.com/naturecommunications
modiﬁed off-line using common software packages such as Excel.
The templates use controlled vocabularies (e.g. for tissue, tax-
onomy or instrument description) to facilitate user input and
simplify data exchange. They can be extended for harmonisation
with other standard initiatives such as the HUPO Proteomics
Standards Initiative (http://www.psidev.info). Additional glyco-
related ontologies are proposed (Supplemenary Data 2) and will
be expanded in line with existing ontologies proposed by the
MIRAGE commission and subsequently included in the
input form.
Step 2: Recording structures and MS fragmentation. The open
source software GlycoWorkbench developed within the EuroCarb
project to assist manual annotation of MS/MS data68 can be used
to record glycan structures. GlycoWorkbench provides a
straightforward interface to draw glycan structures in cartoon
formats using the embedded GlycanBuilder module68. Glycan
structures are stored in a linear format (.gws) for easy parsing and
recording into databases. All recorded data can be stored in an
XML-type Glycoworkbench ﬁle (.gwp ﬁle extension) (Supple-
mentary Fig. 1). A Glycoworkbench template is available at
https://unicarb-dr.biomedicine.gu.se/generate and an example of
a ﬁlled in ﬁle is available in Supplementary Data 3. Glyco-
Workbench allows the recording of individual structures as a
“Scan” with associated fragment data (fragment list is imported
from MS software as centroided data). We suggest utilizing the
ability of GlycoWorkbench to record ion trees, using Glyco-
workbench “Scans” to record MS2 (i.e. MS/MS) for each struc-
ture, and sub-“Scans” to record MS3, MS4 etc. A
GlycoWorkbench ﬁle that includes several structures and MSn
data, for each structure “Scans” and sub-“Scans” needs to be
deﬁned directly under the “Workspace” item.
Supplementary Fig. 1 shows the sections that are typically
included in a.gwp ﬁle. A tag is represented by the “<” and “>”
symbols and deﬁnes the different elements in a ﬁle. These
elements are delimited by a start tag e.g. <scan> and an end tag,
e.g. </scan>. The example shown in Supplementary Fig. 1 belongs
to a single structure somewhat simpliﬁed, highlighting important
MIRAGE tags. In order to be MIRAGE-compatible, we
introduced a “Notes” section for recording orthogonal assign-
ment methods, scoring and validation (see “MIRAGE parameters
in UniCarb-DR” below). The format of the “Notes” section needs
to be respected in order to upload its content to UniCarb-DR (see
Supplementary Methods for more details on the proposed
“Notes” format).
Step 3: Depositing MS raw ﬁles. To host the vast volume of
glycomics MS raw data, we propose a model of data sharing
similar to the one implemented in proteomics by the Proteo-
meXchange consortium69 that includes PRIDE70 and JPOST
(Japan ProteOme STandard Repository/Database), among others.
To provide open data access that complies with the MIRAGE
requirements, we engaged with JPOST. We developed a pipeline
enabling permanent data storage in GlycoPOST (http://glycopost.
glycosmos.org/), a dedicated repository for MS-based glycomics
data. The current model requires submission of MS raw data to
GlycoPOST, whilst MIRAGE and GlycoWorkbench ﬁles are
uploaded and read by the UniCarb-DR submission workﬂow. To
further simplify this process, we are working on integrating
submission of raw data, annotated spectra and MIRAGE meta-
data in a seamless workﬂow using both UniCarb-DR and Gly-
coPOST (Fig. 2). Meanwhile, the applications are streamlined
since the same MIRAGE spreadsheets are used in both applica-
tions and the user has the option of including GlycoPOST gen-
erated URLs of raw data into MIRAGE spreadsheets before
submission to UniCarb-DR. GlycoPOST also accepts and stores
other types of ﬁles, allowing users to upload information about
experimental design, sample log ﬁles including quality control
samples and blank runs, as well as additional information that is
potentially useful for checking the quality and reproducibility of
glycomic experiments containing multiple samples. Hence, data
repositories and the MIRAGE commission will depend on each
other when the next version of guidelines is to be developed.
Alternatives to GlycoPost for the long-term storage of MS raw
data can potentially be included in the workﬂow. For instance, we
have also used an MS Laboratory Information Management
System called Proteios Software Environment (http://www.
proteios.org)71 to upload data to Swestore (http://www.snic.se/
allocations/swestore/), where Swestore generated Uniform
Resource Identiﬁers (URIs) that have been included as part of
scientiﬁc publications72. In this case, MS raw data are provided
both as vendors’ preferred format and as ﬁles converted into the
open source mzML format73. The mzML format is not only
describing spectral data but also contains information requested
in the MIRAGE guidelines. In the short term, we strongly
recommend uploading mzML data separately to GlycoPOST or
other repositories for non-vendor software dependent data access.
In the long term, this submission of raw MS data can be inte-
grated in the UniCarb-DR upload. We note that the MIRAGE
bioinformatics subgroup has considered mzIdentML74 and
mzTab75 potential formats that could be augmented with gly-
comics data, and this will also be implemented in the long term.
Step 4: Registration of submitted glycan structures. GlyTou-
Can55 is a glycan structure repository promoted by the glyco-
community as the prime location for generating unique identi-
ﬁers for individually reported glycan structures and compositions.
Glycan structures should be submitted to this repository as part of
the publication of glycomics data. To avoid duplicate submissions
to both UniCarb-DR and GlyTouCan we have developed a tool
that assesses whether the structures submitted to UniCarb-DR are
already deposited in GlyTouCan. In this case, the GlyTouCan ID
provides a link to UniCarb-DR. If a UniCarb-DR submitted
structure is not available in GlyTouCan, a new ID will be gen-
erated and communicated to UniCarb-DR. This process will
commence after the submission of data to UniCarb-DR.
MIRAGE parameters in UniCarb-DR. The MIRAGE guidelines
are generic and ﬂexible in order to collect information from
different types of experiments studying glycoconjugates. How-
ever, the use of commonly deﬁned vocabularies is required to
compare data within UniCarb-DR and to share data with other
glycomics and life science databases. To preserve the ﬂexibility of
the MIRAGE guidelines in the reporting process we propose free
text ﬁelds to describe experiments, whilst a rigorous reporting
language is implemented only for key MIRAGE parameters (e.g.,
tissue, MS device). Inspired by the organization of PRIDE76, four
different types of formats of the MIRAGE parameters were
encoded in UniCarb-DR (Table 1) and outlined in the Supple-
mentary Methods and Supplementary Data 2. To comply with the
controlled vocabulary but still enable glossary update, new terms
can be suggested by sending a request to administrators of
UniCarb-DR at http://unicarb-dr.biomedicine.gu.se/about.
Upload of MIRAGE compatible MS/MS spectra to UniCarb-
DR. MIRAGE-compliant data sets along with data stored in.gwp
ﬁles of both individual intact structures and fragmentation
spectra can be submitted as supplementary material associated
with a publication. We also propose uploading these collected and
structured glycomic information (spreadsheets and.gwp ﬁles) to
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http://unicarb-dr.biomedicine.gu.se/uploadData. Before upload-
ing, the user is required to register at http://unicarb-dr.
biomedicine.gu.se/signup. The database allows structures of full
and partial assignment to be uploaded (Fig. 3). The reporting of
orthogonal methods (i.e. NMR, HPLC retention time mapping,
and chemical/enzymatic treatment) is also possible and justiﬁes
the fact that UniCarb-DR can be used to accept structures where
MS, but not MSn data, has been collected. Figure 3, displays
examples of assigned structures in UniCarb-DR (http://unicarb-
dr.biomedicine.gu.se/references/1), both with and without asso-
ciated fragmentation data. In the latter case, structures were
assigned based on retention time (RT) and biosynthetic
Table 1 Examples of parameters identiﬁed and included in the MIRAGE guidelines
Deﬁned formats Existing ontologies New parameters in glycoanalytics Free text
Unique identiﬁers for structure
and entry
Cell lines www.clo-ontology.
org/
Treatments and orthogonal methods
for isolation/characterisation
Growth/harvest conditions for
recombinantly produced material
Dates Species www.ncbi.nlm.nih.
gov/taxonomy
Software used for data processing
and structure assignment
Treatments and/or storage conditions
for material isolated from tissues
Oligosaccharide structure (.gws,
glyco-CT84 and WURCS85)
Tissues meshb.nlm.nih.gov/
record/ui?ui=D014024
MS scoring method Synthesis steps for chemically derived
material
MS devices www.ebi.ac.uk/
ols/ontologies/ms
Validation of assigned structure Puriﬁcation steps
Software www.ebi.ac.uk/ols/
ontologies/ms
Sprayer features
Attached proteins www.
uniprot.org/
Voltages and other parameters relevant
for ESI experiments
CID/HCD settings
The columns describe (from left to right): deﬁned formats to control the input and presentation of certain data, ontologies or existing vocabulary that can be adopted from various sources, parameters
that need to be expanded into ontologies or controlled vocabulary to use in glycomics, free unrestricted text
MS information
Observed precursor: 986.27
Theoretical reducing mass: 1972.71
α
α
β
β
β β
β
β
β3
3
4 4
3
3
6
6
4
α
β β
β
3
3
66S
S
4
Retention time: 16.61
No spectra available
No spectra available
MS information
MS information
Observed precursor: 661.18
Observed precursor: 588.17
Theoretical reducing mass: 1176.35
Theoretical reducing mass: 1322.41
Retention time: 11.73
Retention time: 21.85
MS information
Observed precursor: 1056.27
Theoretical reducing mass: 1055.37
Retention time: 9.83
a
b
c
d
Fig. 3 Different types of entries managed by the UniCarb-DR submission tool. The glycan structures are displayed in SNFG cartoon notation83. a Structure
proposed from LC-MS without an LC-MS/MS spectrum. b Fully assigned structure with an associated LC-MS/MS spectrum. c Partially assigned structure
proposed from LC-MS without an LC-MS/MS spectrum. d Partially assigned structure with an associated LC- MS/MS spectrum
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knowledge about the constituting monosaccharides, linkage
position and conﬁguration. Observed RT is of course of limited
use outside a particular experiment. Hence, we promote record-
ing relative RT using external RT markers that generate, for
instance, a nominal size corresponding to number of glucose
units (GU)77 or relative to an internal common landmark
oligosaccharide78.
We have assembled an expandable list of treatments and
orthogonal methods commonly used for isolation/characterisa-
tion in glycomics experiments (Table 1 and Supplementary
Data 2). The current records in UniCarb-DR have been uploaded
using data generated in various laboratories by researchers in the
author list. During this process we found that the requirement to
record the full information about individual structures (e.g.
scoring and orthogonal method validation) is time consuming
due to lack of software, and is often not feasible. Hence, UniCarb-
DR is also accepting data with partial MIRAGE records for an
individual structure, requiring only the record of the precursor
ion mass but no information about scoring and validation. Many
authors of this paper are part of the MIRAGE committee. In light
of these limitations, we have proposed to only require partial
MIRAGE compliance for submitted records of an individual
structure, with the commitment to move towards full MIRAGE
compliance as glycomics software develops further.
Discussion and future perspectives
The lack of an established formalised description of glycomics
experiments may stall progress in the glycobiology ﬁeld. The
research community has always relied on sharing scientiﬁc
results. Here, we are proposing a solution for sharing glycomics
structures with associated MS experimental conditions and data.
For this we are using spreadsheets in combination with Glyco-
Workbench ﬁles. This format is a step towards enforcing
MIRAGE-compliant scientiﬁc publications in glycomics. Past
experience in introducing guidelines for glycomics studies as part
of publications79 has shown that, if there is a clear pathway and
format, researchers will conform to get their manuscripts pub-
lished in quality journals. With the tools presented in this report,
glycomics MS/MSn reporting standards can be adopted at an
early stage of a project. The spreadsheet can be completed and
modiﬁed as the project unfolds and the use of GlycoWorkbench
ﬁles for saving glycomic structural interpretations can be imple-
mented for data housekeeping. Both the spreadsheet and the.gwp
formats are ﬂexible enough to support a variety of glycomics MS,
requiring only limited modiﬁcations of templates provided.
Hence, journal editors will be in the position to ensure MIRAGE
compliance by requesting that authors provide these template
ﬁles as supplementary data. The MIRAGE committee is con-
tinuously corresponding with relevant journal editors on novel
MIRAGE protocols, software tools and repositories to implement
MIRAGE guidelines as part of the publication requirements. With
an increasing awareness of MIRAGE formats and associated
enabling technologies, we expect that an increasing number of
researchers and reviewers will insist that, not only their own, but
also other groups’ data are MIRAGE-compliant in scientiﬁc
publications.
The use of spreadsheets (generated form web form, see Sup-
plementary Data 1), deposition of raw data (e.g. in GlycoPost)
and the GlycoWorkbench.gwp format are supporting the upload
of glycomics MS metadata to UniCarb-DR. This workﬂow has
been tested for datasets of intact as well as reducing-end-
derivatized glycans, which were analysed by MS, LC-MS and
-MS/MS in negative and positive ion modes using CID and HCD
fragmentation. All the data can be assembled manually, allowing
the workﬂow to be used by both beginners in glycomics as well as
advanced glycomic MS institutes. However, another purpose of
deﬁning the upload format is to provide a template for the output
from software-aided glycomic discovery pipelines. The Glyco-
Workbench structure format has already been adopted in other
glycomic commercial (GlycoQuest, Bruker, Bremen Germany)
and academic (GRITS Toolbox (http://www.grits-toolbox.org/)
software projects66. Hence, automated submission to UniCarb-
DR is likely to be easily implemented for these tools.
The focus of this report is on N- and O-linked glycans released
from proteins and their spectra generated by CID and HCD. This
is because the vast majority of data currently available are N- and
O-linked CID fragmentation data using positive and negative ion
modes. UniCarb-DR will also be able to host CID/HCD data of
free glycans, glycans released from glycolipids and glycosami-
noglycans. In principle, the repository could also host data of
intact glycolipids, but the formalisation of the aglycon is currently
missing in GlycoWorkbench. The lack of detailed structural
information about the glycan moiety in global glycoproteomics
data complicates recording of these data with the workﬂow pre-
sented here. However, the main obstacle for including glyco-
proteomics data is that UniCarb-DR currently is not capturing
peptide sequences and glycosite information, and is not asso-
ciating data to a protein. For the time being, glycopeptide MS data
is being collected in databases such as MS-Viewer80 and, as
partially curated data, in GlyConnect49 where they are integrated
with multiple related sources of information on the recorded
attached glycan composition.
Other workﬂows utilized in glycomics, such as permethyla-
tion and other type of derivatisation recordable in Glyco-
workbench followed by MS with or without coupled LC
separation, are easily implemented if the spectra are from single
isomers. With several isomers present in one spectrum, these
data can still be recorded in GlycoWorkbench (several struc-
tures recorded in one “Scan”), but the UniCarb-DR format will
need to be modiﬁed in future versions to enable easy upload of
this mixed-structure data. Similar concerns apply to workﬂows
involving multi-stage MSn, despite the ﬂexibility of recording
sub-“Scans” in GlycoWorkbench. Glycomic MS workﬂows
including ion mobility MS will require updating the spread-
sheets and Glycoworkbench ﬁles with information about col-
lisional cross sections and ion-mobility parameters currently
not considered in MIRAGE or will need to link to databases
that contain cross section information from carbohydrates such
as GlycoMob81. Fragmentation data generated by ExD or other
type of fragmentation techniques producing non-standard
fragments cannot be recorded in GlycoWorkbench and will
require further adjustments of the UniCarb-DR upload proce-
dure. This would involve expanding the type and associated
metadata for individual fragments. Currently, non-standard
fragment peaklist can be uploaded, without annotation of non-
standard fragments. We also request help from the community
to identify additional major glycomics workﬂows for us to
adapt the data submission accordingly.
In addition to adapting the submission process to a broader
range of experimental workﬂows, we are also aiming to automate
submission to UniCarb-DR. To this end, we plan to accept direct
submissions from glycan structure assignment tools such as
Glycoforest65. In 2020, a web version of Glycoforest will manage
the automation of structure assignment to MS/MS spectra. Gly-
coforest ﬁrst generates consensus spectra from the MS/MS data,
and then assigns structures to the consensus spectra. The
resulting assignments can be manually checked and if necessary
corrected by the user. The direct submission of spectra and their
associated assignments will contribute to the expansion of
UniCarb-DR and help reduce human error in the submission
process.
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The commitment to store glycomics MS datasets is essential.
The annotation of glycomics LC-MS data is currently based only
on the knowledge of the interpreters65, be it a software or a
human researcher or both. From this it can be concluded that it is
highly unlikely that all information from a glycomic raw data set
will be extracted in a single analysis. Hence, glycomic raw MS
data should be considered as libraries that will be re-analysed to
harvest new knowledge and to ask new questions. This is even
more important if glycomics evolves similarly to proteomics and
will increasingly rely on data independent acquisition82 in addi-
tion to data depend acquisition as a means to generate data from
clinical or other reference samples. These glycomics libraries will
provide essential information for hypothesis-driven glycomics.
Similar to PRIDE and ProteomeXchange initiatives, the glycomics
community needs to voice the unanimous opinion that this is
needed, and target both national and international life science e-
infrastructure organizations and journals. The MIRAGE com-
mittee already identiﬁed this requirement by introducing the
recommendation for raw data deposition in the guidelines.
A pipeline for curation of experimental data from data repo-
sitories into databases is changing how curated structural data-
bases will be generated. The previous top-down approach of a
database generator and curator searching literature for informa-
tion will shift to researchers submitting and managing their own
data. Researchers and curators will need software tools to help in
the curation process. The metadata in the reporting guidelines
and evaluation of the accompanying publication, complemented
with present and future biosynthetic knowledge, will aid the
curation process. This process must remain objective and trans-
parent in that information can only be added, but not deleted or
altered (unless permitted by the data supplier). The MIRAGE
guidelines can only be strengthened by such an approach that
supports the unbiased assessment of data quality. The mission of
UniCarb-DR and Unicarb-DB is to support the development of a
knowledgebase of glycan structures by providing the pipeline for
storage and curation of glycomic experimental MS data.
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